These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36260157)

  • 41. Can neoadjuvant chemoradiotherapy combined with immunotherapy benefit patients with microsatellite stable locally advanced rectal cancer? a pooled and integration analysis.
    Yue Y; Cheng M; Xi X; Wang Q; Wei M; Zheng B
    Front Oncol; 2023; 13():1280995. PubMed ID: 37869097
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cell-based immunotherapy approaches for colorectal cancer: main achievements and challenges.
    Shahnazari M; Samadi P; Pourjafar M; Jalali A
    Future Oncol; 2021 Aug; 17(24):3253-3270. PubMed ID: 34156258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
    Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
    Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy combined with local therapy in the late-line treatment of repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer.
    Ding Y; Weng S; Zhu N; Mi M; Xu Z; Zhong L; Yuan Y
    Heliyon; 2023 Nov; 9(11):e22092. PubMed ID: 38058653
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer Patients.
    Germani MM; Carullo M; Boccaccino A; Conca V; Masi G
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
    Akbari V; Kallhor M; Mollashahi B; Movafagh A
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Gut Microbiome, Microsatellite Status and the Response to Immunotherapy in Colorectal Cancer.
    Sillo TO; Beggs AD; Middleton G; Akingboye A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: A case series.
    Zhang Z; Cheng S; Gong J; Lu M; Zhou J; Zhang X; Li J; Shen L; Peng Z
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e33-e39. PubMed ID: 32732092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotherapy: Recent Advances and Its Future as a Neoadjuvant, Adjuvant, and Primary Treatment in Colorectal Cancer.
    Yu I; Dakwar A; Takabe K
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of the molecular characteristics associated with microsatellite status of colorectal cancer patients for the clinical application of immunotherapy.
    Fu J; Jin X; Chen W; Chen Z; Wu P; Xiao W; Liu Y; Deng S
    Front Pharmacol; 2023; 14():1083449. PubMed ID: 36814498
    [No Abstract]   [Full Text] [Related]  

  • 53. Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review.
    Xiao B; Yu J; Ding PR
    Clin Colon Rectal Surg; 2023 Nov; 36(6):378-384. PubMed ID: 37795463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers.
    Chalabi M; Fanchi LF; Dijkstra KK; Van den Berg JG; Aalbers AG; Sikorska K; Lopez-Yurda M; Grootscholten C; Beets GL; Snaebjornsson P; Maas M; Mertz M; Veninga V; Bounova G; Broeks A; Beets-Tan RG; de Wijkerslooth TR; van Lent AU; Marsman HA; Nuijten E; Kok NF; Kuiper M; Verbeek WH; Kok M; Van Leerdam ME; Schumacher TN; Voest EE; Haanen JB
    Nat Med; 2020 Apr; 26(4):566-576. PubMed ID: 32251400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation.
    Wang Q; Shen X; Chen G; Du J
    Int J Cancer; 2023 Aug; 153(4):709-722. PubMed ID: 36752642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series.
    Zhou C; Jiang T; Xiao Y; Wang Q; Zeng Z; Cai P; Zhao Y; Zhao Z; Wu D; Lin H; Sun C; Zhang R; Xiao W; Gao Y
    Front Immunol; 2021; 12():784336. PubMed ID: 34975873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients.
    Wang D; Zhang H; Xiang T; Wang G
    Front Immunol; 2021; 12():762341. PubMed ID: 34721435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Outcome of Patients With Early-Stage Mismatch Repair Deficient Colorectal Cancer Receiving Neoadjuvant Immunotherapy: A Systematic Review.
    Chakrabarti S; Grewal US; Vora KB; Parikh AR; Almader-Douglas D; Mahipal A; Sonbol MBB
    JCO Precis Oncol; 2023 Aug; 7():e2300182. PubMed ID: 37595183
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Analysis of microsatellite instability in endometrial cancer: The significance of minimal microsatellite shift].
    Liang L; Li X; Nong L; Dong Y; Zhang JX; Li D; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):254-261. PubMed ID: 37042135
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond.
    Cohen R; Rousseau B; Vidal J; Colle R; Diaz LA; André T
    Target Oncol; 2020 Feb; 15(1):11-24. PubMed ID: 31786718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.